Marc Decramer
Impact in
- Pulmonary and Respiratory Medicine top 0.01%
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Respiratory and Cough-Related Research
- Inhalation and Respiratory Drug Delivery
- Issues, ethics and legal aspects top 0.05%
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 261
- Respiratory Support and Mechanisms 167
- Respiratory and Cough-Related Research 22
- Neonatal Respiratory Health Research 17
- Physiology 123
- Asthma and respiratory diseases 89
- Co-authors
- Rik Gosselink (85 shared papers)Thierry Troosters (42 shared papers)Wim Janssens (58 shared papers)Thierry Troosters (37 shared papers)Ghislaine Gayan‐Ramirez (70 shared papers)Donald P. Tashkin (37 shared papers)Fábio Pitta (14 shared papers)Steven Kesten (31 shared papers)
- Journals
- American Journal of Respiratory and Critical Care Medicine (38 papers)European Respiratory Journal (37 papers)Respiratory Medicine (29 papers)Journal of Applied Physiology (21 papers)CHEST Journal (17 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Marc Decramer
383 papers receiving 23.4k citations
Marc Decramer's Hit Papers
Peers
Comparison fields: 5 of 183
- Pulmonary and Respiratory Medicine 19.5k
- Issues, ethics and legal aspects 636
- Physiology 9.2k
- Complementary and alternative medicine 2.4k
- Critical Care and Intensive Care Medicine 1.5k
Countries citing papers authored by Marc Decramer
This map shows the geographic impact of Marc Decramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Decramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Decramer more than expected).
Fields of papers citing papers by Marc Decramer
This network shows the impact of papers produced by Marc Decramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Decramer. The network helps show where Marc Decramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Decramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 392 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease Hit paper breakdown → | 2008 | 1571 |
| 2 | Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force Hit paper breakdown → | 1995 | 1248 |
| 3 | Characteristics of Physical Activities in Daily Life in Chronic Obstructive Pulmonary Disease Hit paper breakdown → | 2005 | 936 |
| 4 | Chronic obstructive pulmonary disease Hit paper breakdown → | 2012 | 787 |
| 5 | Peripheral Muscle Weakness Contributes to Exercise Limitation in COPD Hit paper breakdown → | 1996 | 779 |
| 6 | Early exercise in critically ill patients enhances short-term functional recovery* Hit paper breakdown → | 2009 | 691 |
| 7 | Physical Activity and Hospitalization for Exacerbation of COPD Hit paper breakdown → | 2006 | 501 |
| 8 | Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial Hit paper breakdown → | 2005 | 473 |
| 9 | 2005 | 447 | |
| 10 | 2002 | 437 | |
| 11 | Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD Hit paper breakdown → | 2014 | 406 |
| 12 | Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study Hit paper breakdown → | 2013 | 402 |
| 13 | Minimal Clinically Important Differences in Pharmacological Trials Hit paper breakdown → | 2014 | 364 |
| 14 | 2009 | 364 | |
| 15 | 2009 | 359 | |
| 16 | 2006 | 350 | |
| 17 | 2010 | 275 | |
| 18 | Skeletal muscle dysfunction in chronic obstructive pulmonary disease: A statement of the American Thoracic Society and European Respiratory Society | 1999 | 274 |
| 19 | 2012 | 267 | |
| 20 | 2009 | 256 |
About Marc Decramer
Marc Decramer is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Complementary and alternative medicine, Surgery and Endocrine and Autonomic Systems, having authored 392 papers that have together received 24.3k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (261 papers), Respiratory Support and Mechanisms (167 papers), Asthma and respiratory diseases (89 papers), Cardiovascular and exercise physiology (44 papers), Neuroscience of respiration and sleep (28 papers), Respiratory and Cough-Related Research (22 papers), Neonatal Respiratory Health Research (17 papers) and Exercise and Physiological Responses (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (19.5k citations), Issues, ethics and legal aspects (636 citations), Physiology (9.2k citations), Complementary and alternative medicine (2.4k citations) and Critical Care and Intensive Care Medicine (1.5k citations). Marc Decramer has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Rik Gosselink, Thierry Troosters, Wim Janssens, Thierry Troosters, Ghislaine Gayan‐Ramirez, Donald P. Tashkin, Fábio Pitta, Steven Kesten, Bartolomé R. Celli and Martijn A. Spruit. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, Respiratory Medicine, Journal of Applied Physiology and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.